Answer
The safety and efficacy of Besremi (ropeginterferon alfa-2b) in children and adolescents have not been established, and no data are available.
Sources for this answer
- Besremi 250 micrograms/0.5 mL solution for injection in pre-filled penAOP Orphan Ltd · emc · SmPC §4.2 Posology and method of administration · Version 10Document updated
Sources checked